Oncotelic Therapeutics
Why Robinhood?
You can watch OTLC and buy or sell other stocks, ETFs, and their options commission-free!About OTLC
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing.
OTLC Key Statistics
Stock Snapshot
The current Oncotelic Therapeutics(OTLC) stock price is $0.05, with a market capitalization of 21.11M. The stock trades at a price-to-earnings (P/E) ratio of 0.09.
On 2026-06-05, Oncotelic Therapeutics(OTLC) stock moved within a range of $0.05 to $0.05. With shares now at $0.05, the stock is trading 0.0% above its intraday low and -5.0% below the session's peak.
Trading volume for Oncotelic Therapeutics(OTLC) stock has reached 36K, versus its average volume of 291.33K.
The stock's 52-week range extends from a low of $0.02 to a high of $0.11.
The stock's 52-week range extends from a low of $0.02 to a high of $0.11.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.